Publication Cover
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 32, 2019 - Issue 1
22
Views
1
CrossRef citations to date
0
Altmetric
Case Studies

An unusual presentation of an uncommon lymphoma, hepatosplenic T-cell lymphoma

, BS, , MD, , MD & , MD
Pages 129-130 | Received 20 Jun 2018, Accepted 06 Aug 2018, Published online: 07 Jan 2019

  • Visnyei K, Grossbard ML, Shapira I. Hepatosplenic γδ T-cell lymphoma: positive staining, PCR showed this specific gene rearrangement. An overview. Clin Lymphoma Myeloma Leuk. 2013;13(4):360–369. doi:10.1016/j.clml.2013.03.011.
  • Voss MH, Lunning MA, Maragulia JC, et al. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk. 2013;13(1):8–14. doi:10.1016/j.clml.2012.09.002.
  • Wei SZ, Liu TH, Wang DT, Cao JL, Luo YF, Liang ZY. Hepatosplenic γδ T-cell lymphoma. World J Gastroenterol. 2005;11(24):3729–3734. doi:10.3748/wjg.v11.i24.3729.
  • Yabe M, Medeiros LJ, Tang G, et al. Prognostic factors of hepatosplenic T-cell lymphoma: clinicopathologic study of 28 cases. Am J Surg Pathol. 2016;40(5):676–688. doi:10.1097/PAS.0000000000000614.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.